
Sensyne Health
@sensynehealth
We combine clinical AI technology and ethically sourced, de-identified & anonymised data to accelerate medical research and improve patient care.
ID: 961547063531134976
http://www.sensynehealth.com 08-02-2018 10:27:39
1,1K Tweet
1,1K Followers
365 Following

Ready for a for a high-energy discussion on successfully scaling #startups? Join experienced sales executives from Sensyne Health, GoCheck Kids, Arthur Ventures, and Modern Logic. Register → lightercapital.zoom.us/webinar/regist… #digitalhealth #webinar #softwaresales


Sensyne Health & Bayer | Pharmaceuticals have developed an #algorithm that identifies patient subgroups based on clinical factors used anonymised #patientdata from OUH Find out more: ow.ly/IhLR50HVh37


Register now for the next pharmaphorum webinar on 24th February at 2:00 pm as experts from Sensyne Health, @CPI_epigenetics and University of Oxford discuss Synthetic control arms' design, implementation and applications #webinar bit.ly/3gmHSy4


Advancing the clinical trials process bit.ly/3gS6AGC Sensyne Health Ian Bolland The MedTalk Podcast @biopharmboy #medtech #pharma #clinicaltrials #podcast



This week, Thursday 24th February, experts from Sensyne Health, @CPI_epigenetics and University of Oxford will discuss how synthetic control arms have the potential to transform clinical trials, Register now and join us for this informative debate #clinicaltrials bit.ly/3gmHSy4

Effectively Applying AI & Machine Learning in Healthcare. Interesting article where Ray Valentia, VP of Clinical & Martin Gouldstone, CBDO Sensyne Health discuss the role of #AI & ML in #healthcare. Read more: ow.ly/W7wO50I25rC Journal of mHealth #ClicinalAI #PatientCare


Don't miss our webinar tomorrow at 2:00 p.m. GMT hosted by pharmaphorum. Mark Winderlich @CPI_epigenetics, David Clifton, University of Oxford & Martin Gouldstone, Sensyne Health will be discussing #SCA & the challenges using #RWD in #clinicaltrials. Register: ow.ly/x0km50I2e4B


Looking forward to Sensyne Health #webinar at 2:00pm⏰ Mark Winderlich @CPI_epigenetics, David Clifton University of Oxford & Martin Gouldstone to discuss how #SyntheticControlArms can be designed & what challenges should be considered. sensynehealth.com/newsroom/webin… #pharmaceuticals #GIANT2021


Looking forward to welcoming Mark Winderlich @CPI_epigenetics & David Clifton University of Oxford that will be joining Martin Gouldstone Sensyne Health today at 2p.m. GMT to discuss about #SCAs & the challenges using #RWD in #clinicaltrials.Register here 👉ow.ly/euMP50I2enA


Join us today, at 2:00 pm GMT / 9:00 am EST for our webinar in association with Sensyne Health, as industry experts discuss the use of #AI and real-world data in #clinicaltrials, register to watch live or on-demand through the link below bit.ly/3gmHSy4

Our first presenter is Sensyne Health chief business officer Martin Gouldstone, to discuss the new world of clinical trials #ppwebinar

One of the biggest challenges is data interoperability, says Sensyne Health’s Martin Gouldstone #ppwebinar





And that’s a wrap! Thank you to everyone who attended our #webinar about how #SCAs & real-world data can redefine clinical trial design, our amazing panel & pharmaphorum for hosting. If you weren’t able to attend you can watch the webinar on demand here: ow.ly/GYty50I3oNF


Could #AI & ML help the development of medicines & improve #patient outcomes? Martin Gouldstone, CBDO and Ray Valencia VP of Clinical Sensyne Health share their thoughts. Read more: ow.ly/lqOi50I8fIY
